Checkpoint Markers and Tumor Microenvironment: What Do We Know?
The cancer microenvironment, or tumor microenvironment (TME), describes the non-cancerous cells present in the tumor, such as fibroblasts, immune cells, and cells that comprise the blood vessels and proteins produced by all of the cells present in the tumor that support the growth of the cancer cell...
Main Authors: | Ramya Ephraim, Sarah Fraser, Kulmira Nurgali, Vasso Apostolopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/15/3788 |
Similar Items
-
Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer
by: Ramya Ephraim, et al.
Published: (2022-12-01) -
Differential Gene Expression of Checkpoint Markers and Cancer Markers in Mouse Models of Spontaneous Chronic Colitis
by: Ramya Ephraim, et al.
Published: (2023-09-01) -
The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer
by: Vanessa Barriga, et al.
Published: (2019-08-01) -
Presbyopia: What We Do Know and What We Do Not Know in 2022
by: Andrzej Grzybowski, et al.
Published: (2023-01-01) -
Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines
by: Nyanbol Kuol, et al.
Published: (2023-10-01)